The Role of Intestinal Microbiota and Diet as Modulating Factors in the Course of Alzheimer's and Parkinson's Diseases

被引:10
|
作者
Czarnik, Witold [1 ]
Fularski, Piotr [1 ]
Gajewska, Agata [1 ]
Jakubowska, Paulina [1 ]
Uszok, Zofia [1 ]
Mlynarska, Ewelina [1 ]
Rysz, Jacek [2 ]
Franczyk, Beata [1 ]
机构
[1] Med Univ Lodz, Dept Nephrocardiol, Ul Zeromskiego 113, PL-90549 Lodz, Poland
[2] Med Univ Lodz, Dept Nephrol Hypertens & Family Med, Ul Zeromskiego 113, PL-90549 Lodz, Poland
关键词
gut-brain axis; microbiota; neurodegenerative diseases; MEDITERRANEAN DIET; GUT MICROBIOTA; BILE-ACID; PROTEIN; BARRIER; MODEL;
D O I
10.3390/nu16020308
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Many researchers propose manipulating microbiota to prevent and treat related diseases. The brain-gut axis is an object that remains the target of modern research, and it is not without reason that many researchers enrich it with microbiota and diet in its name. Numerous connections and mutual correlations have become the basis for seeking answers to many questions related to pathology as well as human physiology. Disorders of this homeostasis as well as dysbiosis itself accompany neurodegenerative diseases such as Alzheimer's and Parkinson's. Heavily dependent on external factors, modulation of the gut microbiome represents an opportunity to advance the treatment of neurodegenerative diseases. Probiotic interventions, synbiotic interventions, or fecal transplantation can undoubtedly support the biotherapeutic process. A special role is played by diet, which provides metabolites that directly affect the body and the microbiota. A holistic view of the human organism is therefore essential.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Herpesviruses in brains in Alzheimer's and Parkinson's diseases
    Hemling, N
    Röyttä, M
    Rinne, J
    Pöllänen, P
    Broberg, E
    Tapio, V
    Vahlberg, T
    Hukkanen, V
    ANNALS OF NEUROLOGY, 2003, 54 (02) : 267 - 271
  • [22] Sleep Disturbances in Alzheimer’s and Parkinson’s Diseases
    Sarah M. Rothman
    Mark P. Mattson
    NeuroMolecular Medicine, 2012, 14 : 194 - 204
  • [23] Neuropathological hallmarks of Alzheimer's and Parkinson's diseases
    Braak, H
    de Vos, RAI
    Jansen, ENH
    Bratzke, H
    Braak, E
    NEURONAL DEGENERATION AND REGENERATION: FROM BASIC MECHANISMS TO PROSPECTS FOR THERAPY, 1998, 117 : 267 - 285
  • [24] Proposed biochemistry of Parkinson's and Alzheimer's diseases
    Robertson, D. S.
    MEDICAL HYPOTHESES, 2017, 109 : 131 - 138
  • [25] Cognitive interventions in Alzheimer's and Parkinson's diseases: emerging mechanisms and role of imaging
    Vemuri, Prashanthi
    Fields, Julie
    Peter, Jessica
    Kloeppel, Stefan
    CURRENT OPINION IN NEUROLOGY, 2016, 29 (04) : 405 - 411
  • [26] Perceptual priming in Alzheimer's and Parkinson's diseases
    Koivisto, M
    Portin, R
    Rinne, JO
    NEUROPSYCHOLOGIA, 1996, 34 (05) : 449 - 457
  • [27] The Evolution of Genetics: Alzheimer's and Parkinson's Diseases
    Singleton, Andrew
    Hardy, John
    NEURON, 2016, 90 (06) : 1154 - 1163
  • [28] Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer’s and Parkinson’s diseases
    Makoto Hashimoto
    Edward Rockenstein
    Leslie Crews
    Eliezer Masliah
    NeuroMolecular Medicine, 2003, 4 : 21 - 35
  • [29] Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases
    Hashimoto, M
    Rockenstein, E
    Crews, L
    Masliah, E
    NEUROMOLECULAR MEDICINE, 2003, 4 (1-2) : 21 - 35
  • [30] Role of Sirtuins and Calorie Restriction in Neuroprotection: Implications in Alzheimer's and Parkinson's Diseases
    Srivastava, Sarika
    Haigis, Marcia C.
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (31) : 3418 - 3433